Journal Article Summary
The article focuses on developing a new contraceptive method using a levonorgestrel-loaded microneedle array patch. This topic is significant due to the high rates of unplanned pregnancies worldwide, which can lead to social and economic challenges for women. Current contraceptive options often require frequent dosing or professional administration, making them less accessible, especially in low-income areas. The study aims to create a long-acting, self-administered contraceptive solution that is both safe and effective.
The researchers formulated liposomes containing levonorgestrel and incorporated them into a microneedle patch designed for transdermal delivery. They characterized the liposomes for size, drug loading, and release behavior, finding that the patch could release the hormone steadily over 28 days. In vivo studies in rats demonstrated that the patch maintained effective hormone levels for over a month, outperforming traditional methods in terms of sustained release and compliance. The microneedles were designed to be painless and biodegradable, making them a promising alternative for contraception.
Despite the encouraging results, the study has limitations, including the need for further research in human trials to confirm safety and efficacy. Readers should be aware that while the microneedle patch shows potential, it is not yet available for public use. It is essential for individuals considering contraceptive options to discuss this and other methods with a healthcare professional to ensure they choose the best option for their needs and circumstances.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Rajput Amarjitsing, Osmani Riyaz Ali M., Khire Achyut, Jaiswal Sanket, Banerjee Rinti. Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo Characterization. Molecules 2022. DOI: 10.3390/molecules27072349. PMID: 35408746. PMCID: PMC9000369.
Featured Pill Pals Product
My Way (Levonorgestrel) 1.5 mg Tablet - Generic For Plan B and Morning After Pill --- Lupin Pharma --- Over The Counter
My Way (Levonorgestrel) 1.5 mg Tablet ā Generic For Plan B and Morning After Pill ā Lupin Pharma ā Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
